HIV Infection–Associated Tuberculosis: The Epidemiology and the Response

Cited by (596)

Items 301–400 of 596

1. Patient Characteristics Associated with Non-Adherence to Tuberculosis Treatment: A Systematic Review
   Ahmed Ali, Martin H. Prins · 2020 · Journal of Tuberculosis Research
2. Immunopathogenesis in HIV-associated pediatric tuberculosis
   Huanbin Xu, Robert V. Blair, Ronald S. Veazey, Xiaolei Wang · 2021 · Pediatric Research
3. Quantitative Assessment of a Dual Epidemic Caused by Tuberculosis and HIV in the Philippines
   Monica C. Torres, Jerrold M. Tubay, Aurelio A. de los Reyes V · 2023 · Bulletin of Mathematical Biology
4. Alterations in natural killer and dendritic cell subsets in individuals with HIV‐associated neurotuberculosis
   Deepashri Rao, Manjunatha M. Venkataswamy, Vasanthapuram Ravi, Parthasarathy Satishchandra, Anita Sudhir Desai · 2018 · Journal of Medical Virology
5. Ethnicity and patient satisfaction with tuberculosis care: A cross‐sectional study
   Jean P. Mukasa, Nel Glass, George Mnatzaganian · 2015 · Nursing and Health Sciences
6. HIV in Africa: Challenges and Directions for the Next Decade
   Bruce L. Gilliam, Devang M. Patel, Rohit Talwani, Zelalem Temesgen · 2011 · Current Infectious Disease Reports
7. HIV prevalence in the Israeli tuberculosis cohort, 1999–2011
   Zohar Mor, Moshe Lidji, Daniel Chemtob, Noa Cedar, Itamar Grotto · 2014 · BMC Public Health
8. Current status on health sciences research productivity pertaining to Angola up to 2014
   Maria do Rosário Sambo, Albano Vicente Lopes Ferreira · 2015 · Health Research Policy and Systems
9. Implementation and Operational Research
   Suzue Saito, Philani Mpofu, E Jane Carter, Lameck Oteko Diero, Kara Wools‐Kaloustian, Constantin Theodore Yiannoutsos, Beverly Sue Musick, Simon Tsiouris, Geoffrey R. Somi, John Ssali et al. · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
10. The effect of partner HIV status on motivation to take antiretroviral and isoniazid preventive therapies: a conjoint analysis
    Hae‐Young Kim, Colleen F. Hanrahan, David W. Dowdy, Neil Alexander Martinson, Jonathan Eric Golub, John F. P. Bridges · 2018 · AIDS Care
11. HIV , HCMV and mycobacterial antibody levels: a cross‐sectional study in a rural Ugandan cohort
    Lisa K Stockdale, Stephen Nash, Angela Nalwoga, Lorna Gibson, Hannah Painter, John G. Raynes, Gershim Asiki, Robert Newton, Helen A. Fletcher · 2018 · Tropical Medicine & International Health
12. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS
    Yung‐Feng Yen, I-An Jen, Pei‐Hung Chuang, Marcelo Chen, Yu-Ching Lan, Chun-Yuan Lee, Yi‐Ming Arthur Chen · 2018 · Annals of Epidemiology
13. SURGICAL TREATMENT OF TUBERCULOSIS IN HIV PATIENTS
    Mikhail Valerevich Sinitsyn, N. Yu. Virskiy, Titiukhina Mv, Boris Barskiy, Tamila Ismailovna Abu Arkub, M.V. Kalinina · 2018 · Tuberculosis and lung diseases
14. Contributory Factors to Successful Tuberculosis Treatment in Southwest Nigeria: A Cross-Sectional Study
    Olanrewaju Oladimeji, Kelechi Elizabeth Oladimeji, Mirabel Kah-Keh Nanjoh, Lucas Banda, Olukayode Ademola Adeleke, Teke Ruffin Apalata, Jabu Mbokazi, Francis Leonard Mpotte Hyera · 2022 · Tropical Medicine and Infectious Disease
15. Expression, purification and characterization of Esx-1 secretion-associated protein EspL from Mycobacterium tuberculosis
    Shuangliang Tian, Hanyu Chen, Tao Sun, Huilin Wang, Xuelian Zhang, Yan Liu, Jin‐Mei Xia, Chenyun Guo, Donghai Lin · 2016 · Protein Expression and Purification
16. Xpert MTB/RIF and Xpert Ultra assays for pulmonary tuberculosis and rifampicin resistance in adults irrespective of signs or symptoms of pulmonary tuberculosis
    Adrienne E. Shapiro, Jennifer M. Ross, Ian Schiller, Mikashmi Kohli, Nandini Dendukuri, Karen R Steingart, David J. de L. Horne · 2020 · Cochrane Database of Systematic Reviews
17. Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection
    Vivek Gopalakrishnan, Eliezer L. Bose, Usha Nair, Yuwei Cheng, Musie S Ghebremichael · 2020 · BMC Infectious Diseases
18. No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients
    Glauco Henrique Balthazar Nardotto, Valdes Roberto Bóllela, Adriana Rocha, Oscar E. Della Pasqua, Vera Lúcia Lanchote · 2021 · Clinical and Translational Science
19. Prevalence and associated factors of tuberculosis among isoniazid users and non-users of HIV patients in Dessie, Ethiopia
    Wondwosen Mebratu, Shambel Wedajo, Semira Mohammed, Abel Endawkie, Yeshiwork Damtew · 2022 · Scientific Reports
20. Treatment outcome and its associated factors among HIV-MTB co-infected patients in Sichuan, China: A retrospective study
    Ni Yang, Chuang Chen, Jinge He, Jing Li, Yin Zhong · 2022 · Medicine
21. Predictors of Re-Emerging Tuberculosis: A Review
    Rafiq Shajahan, Parasakthi Navaratnam, Ganesh Kasinathan, Amudha Kadirvelu, Naganathan Pillai · 2016 · OALib
22. RESOURCES OF THE RUSSIAN MEDICAL UNITS PROVIDING CARE FOR THOSE WITH SOCIALLY IMPORTANT INFECTIOUS DISEASES
    Yu. V. Mikhaylova, O B Nechaeva · 2019 · Tuberculosis and lung diseases
23. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to Mycobacterium tuberculosis
    Priyanka Namdev, Shiv Patel, Brandi Ann Terrance Elize Sparling, Ankita Garg · 2021 · Frontiers in Immunology
24. Prevalence of HIV infection among patients with pulmonary tuberculosis in a rural tertiary hospital in Nigeria
    Bankole Henry Oladeinde, Mitsan Olley, AdekunleAbdufattai Onifade, Odaro Stanley Imade · 2014 · Nigerian Journal of Experimental and Clinical Biosciences
25. Comparative Analysis of Ziehl-Neelsen and Genexpert Techniques for the Diagnosis of Tuberculosis in Human Immuno-Deficiency Virus Positive Patients in Benin City
    Ochei Kingsley Chinedum, Adagbonyin Emwiomwan, Emmanuel Ifeanyi Obeagu, Aminu Babayi · 2017 · Annals of Clinical and Laboratory Research
26. The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in Mycobacterium tuberculosis isolates from untreated pulmonary Tuberculosis cases in urban Blantyre, Malawi
    Geoffrey Peterkins Kumwenda, Geoffrey A. Chipungu, Derek James Sloan, Yankho Kaimila, Kondwani Chiumya, Harry Pangani · 2018 · Malawi Medical Journal
27. Harnessing the Prevention Benefits of Antiretroviral Therapy to Address HIV and Tuberculosis
    Reuben Granich, Ying-Ru Jacqueline Lo, Amitabh Bipin Suthar, Marco Vitória, Rachel Clare Baggaley, Carla Makhlouf Obermeyer, Craig McClure, Yves Souteyrand, Jos Perriëns, James G. Kahn et al. · 2011 · Current HIV Research
28. Single-cell RNA sequencing in tuberculosis: Application and future perspectives
    Yuejuan Zhan, Qiran Zhang, Wenyang Wang, Wenyi Liang, Chengdi Wang · 2024 · Chinese Medical Journal
29. Immune defense and immune evasion in Mycobacterium tuberculosis Infection: Inspirations and challenges for host directed therapy
    Jiaxiang Li, Yilin Liu, Yongdui Ruan, Xinen Kong, Xiaoying Jin, Jiajun Wang, Kangsheng Liao, Ling Shen, Jiang Pi · 2025 · Microbial Pathogenesis
30. Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against Mycobacterium tuberculosis H37Rv: an immuno-informatics approach
    Ajit Kumar, Priyanka Sharma, Akanksha Arun, Laxman S. Meena · 2022 · Journal of Biomolecular Structure and Dynamics
31. Community-Wide Universal HIV Test and Treat Intervention Reduces Tuberculosis Transmission in Rural Uganda: A Cluster-Randomized Trial
    Carina Marquez, Mucunguzi Atukunda, Joshua R. Nugent, Edwin D. Charlebois, Gabriel Chamie, Florence Mwangwa, Emmanuel Ssemmondo, Joel Kironde, Jane Kabami, Asiphas Owaraganise et al. · 2024 · Clinical Infectious Diseases
32. Combined antiretroviral and antituberculosis drug resistance following incarceration
    Katharine Elizabeth Stott, Túlio de Oliveira, Richard J. Lessells · 2013 · Southern African Journal of HIV Medicine
33. A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis
    Satoshi Ikegame, Kentaro Wakamatsu, Akira Kajiki, Masaki Fujita, Yoichi Nakanishi · 2010 · Journal of Infection and Chemotherapy
34. Do clinical decision-support reminders for medical providers improve isoniazid preventative therapy prescription rates among HIV-positive adults?: study protocol for a randomized controlled trial
    Eric P Green, Caricia Catalani, Lameck Oteko Diero, E Jane Carter, Adrian F. Gardner, Charity Ndwiga, Aggrey Keny, Philip Owiti, Dennis M Israelski, Paul Biondich · 2015 · Trials
35. Pneumonia in HIV-Infected Patients
    Seda Tural Önür, Levent Dalar, Sinem İliaz, Arzu Didem Yalçın · 2016 · Eurasian Journal of Pulmonology
36. Identification of HLA ‐ DRB 1*09:01‐restricted Mycobacterium tuberculosis CD 4+ T‐cell epitopes
    Sudong Liu, Shimeng Zhang, Hui Wang, Jian‐Chun He, Xiao‐Fan Yang, Xialin Du, Li Ma · 2016 · FEBS Letters
37. Tuberculosis and HIV Coinfection–the Challenge in the Prevention, Detection and Treatment of Tuberculosis
    Yiyi Wang, Qi Wu, Wei Zhang, Ning Zhang · 2018 · Current Bioinformatics
38. The Impact of Anti-Retroviral Therapy on Tuberculosis Detection at the National Level in South Africa
    Zoë M McLaren, Alana R. Sharp, Elizabeth Brouwer, Ananta Nanoo · 2018 · American Journal of Tropical Medicine and Hygiene
39. Health Considerations for HIV-Infected International Travelers
    Daniel L. Bourque, Daniel A. Solomon, Paul Edward Sax · 2019 · Current Infectious Disease Reports
40. HIV coinfections with tuberculosis among HIV-1 infected individuals in old cross river state, Nigeria
    Iheanyi Omezuruike Okonko, Ugochi Immaculate Ejike, Chioma Innocent-Adiele, T. I. Cookey · 2020 · Journal of Immunoassay and Immunochemistry
41. Opportunities for Tuberculosis Diagnosis and Prevention among Persons Living with HIV: A Cross-Sectional Study of Policies and Practices at Four Large Ryan White Program-Funded HIV Clinics
    Lisa Pascopella, Julie C. Franks, Suzanne M. Marks, Katya L. Salcedo, Kjersti Schmitz, Paul W. Colson, Yael Hirsch‐Moverman, Jennifer Flood, Jennifer N. Sayles · 2014 · PLoS ONE
42. Accelerated failure time modelling of Tuberculosis predictors in HIV/AIDS patients in Albert Luthuli Municipality of South Africa
    Pepukai Bengura, Principal Ndlovu, Mulalo Annah Managa · 2020
43. Integration of HIV Testing in a Community Intervention for Tuberculosis Screening Among Household Contacts of Patients with Tuberculosis in Cameroon and Uganda
    Boris Tchakounte Youngui, Daniel Atwine, David Otai, Anca Vasiliu, Bob Ssekyanzi, Colette Sih, Rogacien Kana, Rinah Arinaitwe, Benjamin Cuer, Leonie Simo et al. · 2024 · JAIDS Journal of Acquired Immune Deficiency Syndromes
44. Videoendosurgical techniques in diagnosis of chest diseases in HIV patients
    M. V. Synitsyn, Mikhail Nikolaevich Reshetnikov, Irina Sokolina, Д. В. Плоткин, N. Yu. Virskiy, Boris Barskiy · 2017 · Endoscopic Surgery
45. Epidemiology of Drug-Susceptible, Drug-Resistant Tuberculosis and HIV in Africa
    Kogieleum Naidoo, Nikita Naicker · 2019 · Springer eBooks
46. Drug Resistance of Mycobacterium tuberculosis Based on Whole-Genome Sequencing in the Yi Ethnic Group, Sichuan Province, China
    Wenfeng Gao, Xiaoru Chen, Liang Yao, Jing Li, Yuan Gao, Ting Li, Yunkui Li, Weina Wang, Shu Zhang, Jinge He · 2023 · Journal of Immunology Research
47. Transmission and resistome of extremely drug-resistant tuberculosis in Beijing, China: A retrospective population-based epidemiological study
    Haiping Guo, Jun An, Shanshan Li, Beichuan Ding, Zhiguo Zhang, Wei Shu, Yuanyuan Shang, Yi Wang, Ken Cheng, Yufeng Wang et al. · 2023 · Journal of Infection and Public Health
48. Advances in Antiretroviral Therapy for Patients with Human Immunodeficiency Virus-Associated Tuberculosis
    Xiaoqin Le, Yinzhong Shen · 2024 · Viruses
49. Exosomal microRNAs associated with tuberculosis among people living with human immunodeficiency virus
    Yujiao Jin, Yuan Liu, Wenyan Yu, Yan Zhang, Kenv Pan, Miaochan Wang, Aifang Xu · 2024 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
50. Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIV
    R. Borse, Bharat Randive, S. K. Mattoo, P. Malik, H. Solanki, Amita Gupta, Richard E. Chaisson, Vidya Mave, Nishi Suryavanshi · 2024 · IJTLD OPEN
51. Exploitation of Culture Medium forMycobacterium tuberculosis
    Hye-Jin Kim, Sungweon Ryoo · 2011 · Journal of Bacteriology and Virology
52. Hypercalcemia in patients with tuberculosis and HIV infections in Northwest Ethiopia
    Bemnet Tedla, Solomon Meseret Woldeyohannes, Tomoki Yabutani, Beyene Moges, Afework Kassu · 2012 · Asian Pacific Journal of Tropical Disease
53. Effectiveness and Safety of Concurrent Use of First-Line Antiretroviral and Antituberculous Drugs in Rwanda
    Justin Ntokamunda Kadima, Marie Françoise Mukanyangezi, Claude Bernard Uwizeye · 2014 · Journal of Tropical Medicine
54. WIPO Re:Search: Catalyzing Collaborations to Accelerate Product Development for Diseases of Poverty
    Roopa Ramamoorthi, Katy M. Graef, Anatole F. Krattiger, Jennifer Dent · 2014 · Chemical Reviews
55. Inappropriate of In vitro antimicrobial and anticancer activities from cashew (Anacardium occidentale L.) nut shell extracts
    Yuttana Sudjaroen, Kanittada Thongkao, Kowit Suwannahong · 2018 · Journal of Pharmaceutical Negative Results
56. Study of Antimicrobial Quinolones and Structure Activity Relationship of Anti-Tubercular Compounds
    Mohammad Asif · 2015 · Research and reviews : journal of chemistry
57. Burkitt lymphoma associated with human immunodeficiency virus infection and pulmonary tuberculosis
    Victoria Bîrluțiu, Rareş Mircea Bîrluţiu, Ioan Sorin Zaharie, Mariana Sandu · 2020 · Medicine
58. Lack of latent tuberculosis (TB) screening and delay in anti-retroviral therapy initiation in HIV-TB co-infection: an 11-year study in an intermediate TB-burden country
    Vannesa Teng Yue May, Yan Ting Chua, Eunice En Ni Lai, Shilpa Mukherjee, Jessica Michaels, Chen Seong Wong, Liang Shen, Yee‐Sin Leo, Barnaby Edward Young, Sophia Archuleta et al. · 2021 · International Journal of Infectious Diseases
59. Compliance and knowledge of health professionals regarding airborne precautions
    Hélio Galdino Júnior, Moníque Lopes de Souza, Luzinéia Vieira dos Santos, Anaclara Ferreira Veiga Tipple · 2015 · Rev Rene
60. Tuberculosis Treatment Completion in a United States/Mexico Binational Context
    Celina I. Valencia, Kacey C. Ernst, Cecilia Rosales · 2017 · Frontiers in Public Health
61. Tuberculosis incidence in country of origin is a key determinant of the risk of active tuberculosis in people living with HIV: Data from a 30‐year observational cohort study
    Helena White, Hajra Okhai, Peter Kirwan, Sonia H. Rafeeq, Helen Dillon, Phillip Hefford, Martin J Wiselka, Manish Pareek · 2021 · HIV Medicine
62. The multi-step process of building TB/HIV collaboration in Cambodia
    Mao Tan Eang, Mean Chhi Vun, Kim Eam Khun, Sovannarith Samreth, Seng Sopheap, Bora Ngauv, Rajendra Prasad Hubraj Yadav, Masami Fujita, Bernard Tomas, Massimo Ghidinelli et al. · 2012 · Health Research Policy and Systems
63. Factors influencing tuberculosis preventive practices among people living with HIV/AIDS enrolled in secondary health facilities in Lagos, Nigeria
    Sunday Olakunle Olarewaju, Roseline Oluyemisi Akande, Charity E. Abu, Sunday Charles Adeyemo · 2023 · African Health Sciences
64. A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness
    Carlo Maria Bellanca, Simone Pietro Polosa, Egle Augello, Giulia Di Benedetto, Chiara Burgaletto, Anna Flavia Cantone, Gabriella Gaudio, Giuseppe Nunnari, Davide Campagna, Jennifer M. Nailes et al. · 2025 · Frontiers in Pharmacology
65. Mortality and associated factors among children with the double burden of human immunodeficiency virus and tuberculosis in African countries: a systematic review and meta-analysis
    Derara Girma, Leta Adugna Geleta, Hiwot Dejene, Erean Shigign Malka, Addisu Waleligne Tadesse, Befekadu Tesfaye Oyato, Husen Zakir Abasimel, Feyiso Bati Wariso, Dursa Hussein, Getahun Fetensa · 2025 · BMC Infectious Diseases
66. HIV Co-Infection with Hepatotropic Viruses and Mycobacterial Tuberculosis
    Anyaehie Bu · 2013 · Journal of AIDS & Clinical Research
67. Evaluating community knowledge of tuberculosis preventive therapy in rural South Africa
    Carlo Foppiano Palacios, Anthony P. Moll, Roman Shrestha, Tejaswi Kompala, J. Lucian Davis, Salome Charalambous, Lucy Chimoyi, Violet N Chihota, Laurie Andrews, Sheela Shenoi · 2025 · BMC Public Health
68. Mathematical modelling and sensitivity analysis of HIV-TB co-infection.
    S. O. Adewale, I.A. Olopade, G. A. Adeniran, SO Ajao · 2015 · JOURNAL OF ADVANCES IN MATHEMATICS
69. A Multimodal Semiotic Analysis of Social Factors in Tuberculosis Campaigns in South Africa, the United Kingdom and India
    Sabihah Moola, Christo P. Cilliers · 2019 · Communicatio
70. RETRACTED: Clinico-demographic and survival profile of people living with HIV on antiretroviral treatment
    Riyaz Ahamed Shaik, Sharan K Holyachi, Mohammad Sami Ahmad, Mohammad Miraj, Mansour Alzahrani, Ritu Kumar Ahmad, Bader A. Almehmadi, Mohammed Zaid Aljulifi, Meshari A. Alzahrani, Mashael B. Alharbi et al. · 2023 · Frontiers in Public Health · Retracted
71. Mathematical modeling of transmission co-infection tuberculosis in HIV community
    VINA LUSIANA, Prama Setia Putra, Nuning Nuraini, Edy Soewono · 2017 · AIP conference proceedings
72. Sustaining tuberculosis preventive therapy scale-up through direct supportive supervision
    Stanley C. Meribe, Yakubu Adamu, E. Adebayo-Abikoye, I. Lawal, I. Amazue-Ezeuko, Nathan Anelechi Elvis Okeji, Ijeamaka D. Okoye, Patricia Aladi Agaba, R. Nelson, E. Lee et al. · 2020 · Public Health Action
73. Tuberculosis among School Age (6 - 18 Years) Children Seen in University of Port Harcourt Teaching Hospital: A Need for Effective School Health Services
    B. A. Alex-Hart, Nsirimobu Ichendu Paul, Rosemary Ogochukwu Ugwu · 2019 · Journal of Tuberculosis Research
74. Tuberculosis Epidemiology
    Giovanni Sotgiu, Philippe Glaziou, Charalambos Sismanidis, Mario Carlo Raviglione · 2016 · Elsevier eBooks
75. Clinical outcomes of participants of a TB prevalence survey with an abnormal chest X-ray but no evidence of TB disease after a median follow-up of 9 months in Zambia and South Africa
    María Rupérez, Jacob Busang, Linda Mureithi, Kwame Shanaube, Eveline Klinkenberg, Thomas Gachie, James Michael Burnett, Barry R. Kosloff, Petra de Haas, Richard Hayes et al. · 2025 · PLOS Global Public Health
76. Machine learning to improve HIV screening using routine data in Kenya
    Jonathan D. Friedman, Jonathan Mwangi, Kennedy J. Muthoka, Benedette A. Otieno, Jacob O. Odhiambo, Frederick O. Miruka, Lilly Muthoni Nyagah, Pascal Mwele, Edmon Obat, Gonza O. Omoro et al. · 2025 · Journal of the International AIDS Society
77. A case of isoniazid-resistant miliary tuberculosis in which tuberculous meningitis paradoxically developed despite systemic improvement
    Satoshi Ikegame, Kentaro Wakamatsu, Mine Harada, Akira Kajiki, Masaki Fujita, Yoichi Nakanishi · 2011 · Journal of Infection and Chemotherapy
78. Mycobacterium tuberculosis Chaperonin 60 Paralogues Contribute to Virulence in Tuberculosis
    Richard W. Stokes · 2013 · Heat shock proteins
79. Reactivation tuberculosis: role of surveillance
    Andrew R. DiNardo, Elizabeth Guy · 2016 · Expert Review of Anti-infective Therapy
80. Defective Antigen Presentation Leads to Upregulation of PD1 and IL-10 in HIV-TB Co-Infection
    Sharada Ramaseri Sunder, Naveenchandra Suryadevara, Satya Sudheer Pydi, Venkata Sanjeev Kumar Neela, Vijaya Lakshmi Valluri · 2020 · Journal of Interferon & Cytokine Research
81. Multidrug-Resistant Tuberculosis in Imo State, Southeast, Nigeria
    Ita IE Ahiarakwem, Ifeoma Mercy Ekejindu, C N Akujobi, Iloduba Nnaemeka Aghanya · 2020 · Nigerian Journal of Clinical Practice
82. Mitochondrial Metabolism in Alveolar Macrophages of Patients Infected with HIV, Tuberculosis, and HIV/Tuberculosis
    Ling Zhang, Miaotian Cai, Bin Su, Yingmin Ma, Yulin Zhang · 2023 · AIDS Research and Human Retroviruses
83. Prevalence of co-infection of human immunodeficiency virus in diagnosed tuberculosis cases: Meta-analysis.
    Naif H. Alanazi, Asif Hanif · 2024 · PubMed Central
84. Differential Expression of lncRNAs in HIV Patients with TB and HIV-TB with Anti-Retroviral Treatment
    Victoria A. Reid, Enrique Ramos, Raja Veerapandian, Areanna Carmona, Shrikanth S. Gadad, Subramanian Dhandayuthapani · 2024 · Non-Coding RNA
85. Approaches to clinical trials of new anti-TB drugs
    Charles M Bark, Jennifer Joan Furin, John L. Johnson · 2012 · Clinical Investigation
86. HIV Progression Perturbs the Balance of the Cell-Mediated and Anti-Inflammatory Adaptive and Innate Mycobacterial Immune Response
    Andrew R. DiNardo, Anna Maria Mandalakas, Gugu P. Maphalala, Godwin Mtetwa, Temhlanga Mndzebele, Pilar Ustero, Makhosazana Hlatshwayo, Emily Margaret Mace, Jordan Scott Orange, George Makedonas · 2016 · Mediators of Inflammation
87. Outcomes of resectable pulmonary aspergilloma and the performance gap in a high tuberculosis prevalence setting: A retrospective study
    SR Masoud, EM Irusen, CFN Koegelenberg, LJ du Preez, Brian Allwood · 2017 · South African Respiratory Journal
88. Prevalence of chronic obstructive pulmonary disease in patients diagnosed with HIV without prior antiretroviral treatment
    Zaira Romero-López, Fermín Alejandro Rojas-Cisneros, María Dolores Ochoa-Vázquez, Favio Gerardo Rico-Méndez, José Antonio Mata Marín · 2020 · Gaceta Médica de México
89. Relationship between Caregiver’s Quality of Life and Childhood Tuberculosis in Bauchi State, Northeastern Nigeria
    Haruna Ismaila Adamu, T Osoba, Cornelia White, Yakubu Gida · 2018 · OALib
90. DIAGNOSTIC SURGERY IN HIVINFECTED PATIENTS WITH DAMAGE OF CHEST ORGANS
    Mikhail Valerevich Sinitsyn, Mikhail Nikolaevich Reshetnikov, Boris Barskiy, T. I. Abu Arqoub, E. I. Pozdnyakova, Д. В. Плоткин · 2018 · HIV Infection and Immunosuppressive Disorders
91. In silico identification of potential inhibitors against Mycobacterial proteasome
    Rashmi Tyagi, Dhruv Kumar, V. Samuel Raj · 2018 · International Conference on Bioinformatics and Systems Biology (BSB)
92. TB/HIV Coinfection and Other Medical Co-Morbidity in Older Adults (50 - 64 Years) in Botswana: Evidence from 2013 Botswana AIDS Impact Survey (BAIS IV)
    Njoku Ola Ama, Helen A. Ama, Francis Nathan Okurut · 2019 · Advances in Sexual Medicine
93. Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status
    Conor Tweed, Angela M. Crook, Rodney Dawson, Andreas H. Diacon, Timothy Daniel McHugh, Carl M. Mendel, Sarah K Meredith, Lerato Mohapi, Michael E. Murphy, Andrew Nunn et al. · 2019 · BMC Pulmonary Medicine
94. Epidemiological profile of tuberculosis in the prison population of Minas Gerais, Brazil
    Marcos Vinícius Teixeira Martins, Márcio Cesário Cunha Sobrinho, Gabriel Machado de Souza, Stefan Vilges de Oliveira · 2022 · Población y Salud en Mesoamérica
95. Economic efficiency of radiology wards using data envelopment analysis: Case study of Iran
    Ali Keshtkaran, Mohsen Barouni, Ramin Ravangard, Mohammad Yandrani · 2014 · Health
96. Molecular detection of rifampicin resistance by GeneXpert ® assay among treated and untreated pulmonary tuberculosis patients from Khyber Pakhtunkhwa, Pakistan
    Hazır Rahman, Shakir Ullah Khan, Muhamamd Amjad Khan, Muhammad Qasim, Abdul Jabbar, Sadiq Noor, Zakir Khan, Taj Ali Khan, Mubbashir Hussain, Noor Muhammad et al. · 2017 · Journal of Global Antimicrobial Resistance
97. A Review of the Impact of Patent Medicine Vendors in Driving Community Tuberculosis Case Finding in the COVID-19 Pandemic in Nigeria
    Arinze Emmanuel Ajogwu, Onwubiko Iheanyichukwu Samuel, Nnanyelugo Longinus Ochike, Uzoma Chidinma Ajegbo, Chinedu Paschal Maduka · 2024 · Matrix Science Medica
98. Tuberculosis incidence and treatment outcomes in the Tarmaber District, Ethiopia: a five-year retrospective study
    Seble Teklesilassie, Tegenu Gelana, Tilahun Alelign · 2025 · BMC Infectious Diseases
99. The cost‐effectiveness of treating triple coinfection with HIV , tuberculosis and hepatitis C virus
    Gilberto Sánchez‐González · 2016 · HIV Medicine
100. Multifaced pknE: Apoptosis Inhibition, HIV Co-Infection, Host SignalingCross-Talk and in Orchestrating the Physiology of Mycobacterium tuberculosis
     Dinesh Kumar Par, Haman, S. Hassan, S. Narayanan · 2016 · Journal of Microbial & Biochemical Technology